Table 2.
Immediate early (α), early (β), and late (γ) HSV gene expression.
HSV gene expression | Gene | Protein | Expression timing (hpi) | Cell line | References |
---|---|---|---|---|---|
Immediate early (α) | RL2 | ICP0 | 4–8 | Vero, HeLa | Garvey et al., 2014; Lee et al., 2016 |
RS1 | ICP4 | 4–8 | Vero | Garvey et al., 2014 | |
UL54 | ICP27 | 4–8 | Vero | Garvey et al., 2014 | |
US1 | ICP22 | 4–8 | Vero | Garvey et al., 2014 | |
US12 | ICP47 | 4–8 | Vero | Garvey et al., 2014 | |
Early (β) | UL23 | TK | 8–12 | Vero | Garvey et al., 2014 |
UL29 | ICP8 | 8–12 | Vero | Garvey et al., 2014 | |
UL50 | dUTPase | 8–12 | Vero, MRC5 | Garvey et al., 2014; Fox et al., 2017 | |
UL2 | Uracil Deoxyglycosylase | 8–12 | Vero | Garvey et al., 2014 | |
Late (γ) | UL48 | VP16 | 12–18 | Vero, MRC5 | Garvey et al., 2014; Fox et al., 2017 |
UL19 | VP5 | 12–18 | Vero, MRC5 | Garvey et al., 2014; Fox et al., 2017 | |
US6 | gD | 12–18 | Vero, MRC5 | Garvey et al., 2014; Fox et al., 2017 | |
UL27 | gB | 12–18 | Vero, MRC5 | Garvey et al., 2014; Fox et al., 2017 | |
UL53 | gK | 12–18 | Vero | Garvey et al., 2014 | |
UL44 | gC | 12–18 | Vero, MRC5 | Garvey et al., 2014 | |
UL41 | vhs | 12–18 | Vero | Garvey et al., 2014; Fox et al., 2017 |